Background: Soft tissue augmentation with bovine collagen is a common and safe aesthetic procedure. Despite adequate pretreatment testing, allergic reactions can develop. The medical literature provides little guidance to the clinician in the management of bovine collagen hypersensitivity.
Objective: We describe a case of bovine collagen allergy treated with 0.1% topical tacrolimus and corticosteroids.
Methods: Clinical evaluation and management of a patient with bovine collagen hypersensitivity.
Results: Our patient responded to combined therapy with oral corticosteroids and topical tacrolimus.
Conclusion: Topical tacrolimus may be a useful first-line or adjuvant therapy in the management of bovine collagen allergic reactions. Further clinical experience with its use for bovine collagen hypersensitivity is required to determine its true efficacy in this condition.